ReviewProbiotics and antimicrobial proteins2026
Synergistic Effect of Nanoparticles with Probiotics on Gastrointestinal Regenerative Medicine.
Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nature Is a Valuable Source for the Biosynthesis of Nanoparticles and Their Effects on the Treatment of Osteomyelitis.Journal of cellular and molecular medicine · 2025Review
- Probiotics and human health: biological activities, nutritional aspects, immunomodulatory properties, applications, and future perspectives - a comprehensive review.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanomedicine has emerged as a prominent field with significant potential to transform the future of medicine, thereby attracting considerable attention from researchers worldwide. In various studies, nanoparticles with high potential as delivery systems have been used in combination with probiotics, microorganisms that have beneficial health effects when consumed in sufficient doses, in treating inflammatory bowel disease, including ulcerative colitis and Crohn's disease. Nanoparticles are synthesized by various methods, including biological, physical, and chemical, and depending on their size and structure, they produce different effects on the digestive system when combined with probiotics. The study demonstrates that combining various nanoparticles with specific probiotics can effectively modulate intestinal microbiota, reduce inflammation, enhance mucosal barrier function, and boost antioxidant activity, thereby aiding in the treatment of inflammatory digestive diseases. So, future research should further investigate the long-term safety, optimal dosing, and mechanisms of action of these nanoparticle-probiotic combinations in clinical settings to maximize therapeutic benefits.
Indexed as
Identifiers
40778962What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.